Houston, Texas
Colorectal cancer clinical trials in Houston, TX
140 colorectal cancer studies are recruiting participants at sites in Houston as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Houston at a glance
- 140 studies are recruiting at a site in Houston.
- By phase: Early Phase 1 (2), Phase 1 (46), Phase 1/2 (38), Phase 2 (20), Phase 2/3 (2), Phase 3 (8), Phase 4 (1), No phase (10), Observational (13). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (95), university, hospital or other (43), government (2).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Houston
Basic details from each study's public record (the 30 most recently updated of 140). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study sites
- The Methodist Hospital Research Institute · The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06324357 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06385925 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06983743 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Next Oncology - Houston
- Registry record
- NCT07488676 · updated
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- SOTIO Biotech a.s.
- Study site
- NEXT Houston
- Registry record
- NCT07693751 · updated
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT04739072 · updated
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT05195710 · updated
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- No phase
- Ages 18 and older
- Female participants
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT05649072 · updated
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Vividion Therapeutics, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06004245 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Study sites
- NEXT Houston · University of Texas MD Anderson Cancer Center
- Registry record
- NCT06270706 · updated
Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06878131 · updated
Shield Post-Approval Study Protocol
- Observational
- Ages 45 to 81
- All sexes
- Sponsor
- Guardant Health, Inc.
- Study site
- Integrity Advanced Therapeutics, PLLC
- Registry record
- NCT06880055 · updated
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- The University of Texas M. D. Anderson Cancer Center
- Registry record
- NCT06959550 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT07458347 · updated
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07500298 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT07659795 · updated
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- The University of Texas MD Anderson Cancer Center · The University of Texas, MD Anderson Cancer Center - West Houston
- Registry record
- NCT04557449 · updated
Role of Diet on the Microbiome of the Digestive System
- Observational
- Ages 45 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT04666727 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07020221 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study sites
- MD Anderson · NEXT Texas LLC - Houston
- Registry record
- NCT07503808 · updated
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT06102902 · updated
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT05411718 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- The University of Texas - M.D. Anderson Cancer Center · The University of Texas, MD Anderson Cancer Center - West Houston
- Registry record
- NCT07318805 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT07446322 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · Ben Taub General Hospital · Lyndon Baines Johnson General Hospital
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT05334069 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The University of Texas - MD Anderson Cancer Center
- Registry record
- NCT06400472 · updated
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06695845 · updated
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- The University of Texas MD Anderson Cancer Center - Texas Medical Center
- Registry record
- NCT06760819 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Ask about studies near Houston
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
195 studies recruiting across 43 cities.
San Antonio
53 studies recruiting.
Dallas
46 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections